Graham Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-431,766
| Closed | -$283K | – | 1549 |
|
|
2025
Q1 | $283K | Buy |
431,766
+338,591
| +363% | +$222K | 0.01% | 983 |
|
|
2024
Q4 | $95K | Sell |
93,175
-62,967
| -40% | -$64.2K | ﹤0.01% | 1136 |
|
|
2024
Q3 | $135K | Buy |
+156,142
| New | +$135K | ﹤0.01% | 943 |
|
|
2023
Q4 | – | Sell |
-96,102
| Closed | -$57.6K | – | 1283 |
|
|
2023
Q3 | $57.6K | Buy |
96,102
+28,354
| +42% | +$17K | ﹤0.01% | 947 |
|
|
2023
Q2 | $88.1K | Buy |
+67,748
| New | +$88.1K | ﹤0.01% | 886 |
|
|
2022
Q3 | – | Sell |
-311,960
| Closed | -$1.29M | – | 1289 |
|
|
2022
Q2 | $1.29M | Buy |
+311,960
| New | +$1.29M | 0.05% | 343 |
|